Norwick B. H. Goodspeed

Transvascular (TVI) is a development stage medical device company that is definig a new class of intervention for the treatment of vascular diseases and other disorders. Unlike conventional therapies that are limited to treatment within blood vessels, the company's novel therapeutic approach extends beyond the vessel boundaries

Ocular Sciences, Inc. was manufacturer and marketer of contact lenses for annual and disposable replacement regimens. It used to manufacture soft contact lenses such as disposable toric, cosmetic, aspheric, multi-focal, sports and extended-wear lenses. Ocular sciences was marketing their products exclusively to eye care practitioners, both in private practice and retail chains. The company was founded in 1983 and was headquartered in Concord, CA.

Baxter Corp. supplies health care and laboratory products. Its products are used for treating cancer, hemophilia, immune deficiencies, kidney disease, and trauma. The company is headquartered in Mississauga, Canada

Vical, Inc. engages in the research and development of biopharmaceutical products based on patented DNA delivery technologies for the prevention and treatment of serious and life-threatening diseases. It focuses on the antifungal VL-2397, which treats patients with invasive aspergillosis. Its products include Vaxfectin, a cationic lipid formulation optimized to increase the immune response to vaccines. The company was founded by Howard E. Greene, Jr. Timothy J. Wollaeger, Karl Y. Hostetler, and Douglas D. Richman in April 1987 and is headquartered in San Diego, CA.

Part of B. Braun Holding GmbH & Co. KG, McGaw, Inc. is a marketing technology agency that specializes in helping businesses build the perfect martech stack and setup marketing automation for growth. The company is based in Irvine, CA. McGaw implements and tracks analytics to ensure correct implementation and offers expert help with marketing and sales stack implementation, lead generation, funnel optimization, or email automation. In 1997, McGaw was acquired by B. Braun Melsungen AG from IVAX LLC for $400 million.

MicroMed Cardiovascular, Inc. is a medical company engaged in the manufacture and distribution of miniaturized heart pump known as the DeBakey VAD to address congestive heart failure. The company was founded on October 6, 1995 is headquartered in Houston, TX.

FlowCardia, Inc. designs, develops and manufactures endovascular devices. It offers flowmate Injector to optimize the performance of crosser cto recanalization and crosser catheter, a minimally-invasive endovascular device. The firm also provides portfolio of catheter-based technologies to facilitate guidewire crossing of totally occluded coronary and peripheral arteries. The company was founded by Henry Nita and Erik T. Engelson in 2001 and is headquartered in Sunnyvale, CA.